Patents by Inventor Christopher Paszty

Christopher Paszty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sclerostin-binding antibody
    Patent number: 7592429
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: September 22, 2009
    Assignees: UCB SA, Amgen Inc.
    Inventors: Christopher Paszty, Martyn Kim Robinson, Kevin Graham, Alistair James Henry, Kelly Sue Hoffmann, John Latham, Hsieng Sen Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David Winkler, Aaron George Winters
  • Binding agents
    Publication number: 20070110747
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: April 25, 2006
    Publication date: May 17, 2007
    Applicants: UCB S.A., Amgen, Inc.
    Inventors: Christopher Paszty, Martyn Robinson, Kevin Graham, Alistair Henry, Kelly Hoffmann, John Latham, Hsieng Lu, Alastair Lawson, Andy Popplewell, Wenyan Shen, David Winkler, Aaron Winters
  • Epitopes
    Publication number: 20070072797
    Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
    Type: Application
    Filed: April 25, 2006
    Publication date: March 29, 2007
    Applicants: UCB S.A., Amgen, Inc.
    Inventors: Martyn Robinson, Alistair Henry, Alastair Lawson, Hsieng Lu, Christopher Paszty, Kelly Hoffmann, John Latham, David Winkler, Aaron Winters
  • Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
    Publication number: 20060191027
    Abstract: The present invention relates to novel Cloaked-2 polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing Cloaked-2 polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with Cloaked-2 polypeptides.
    Type: Application
    Filed: January 6, 2006
    Publication date: August 24, 2006
    Applicant: AMGEN INC.
    Inventors: Christopher Paszty, Yongming Gao
  • Wnt-1 inhibitory factor-1 (WIF-1) molecules and uses thereof
    Publication number: 20050084487
    Abstract: The present invention provides Wnt-1 Inhibitory Factor-1 (WIF-1) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing WIF-1 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with WIF-1 polypeptides.
    Type: Application
    Filed: December 23, 2003
    Publication date: April 21, 2005
    Inventor: Christopher Paszty